Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

被引:73
作者
Huang, Shih-ying [1 ]
Franc, Benjamin L. [1 ]
Harnish, Roy J. [1 ]
Liu, Gengbo [2 ]
Mitra, Debasis [2 ]
Copeland, Timothy P. [1 ]
Arasu, Vignesh A. [1 ]
Kornak, John [3 ]
Jones, Ella F. [1 ]
Behr, Spencer C. [1 ]
Hylton, Nola M. [1 ]
Price, Elissa R. [1 ]
Esserman, Laura [1 ,4 ]
Seo, Youngho [1 ,5 ,6 ,7 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Florida Inst Technol, Sch Comp, Melbourne, FL 32901 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA
[7] Univ Calif Berkeley, Joint Grad Grp Bioengn, Berkeley, CA 94720 USA
关键词
CLASS DISCOVERY; LUNG; SURVIVAL; QUANTIFICATION; PREDICTION; IMAGES;
D O I
10.1038/s41523-018-0078-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization breast cancer phenotype and prognosis. Eighty-four features were extracted from PET and MR images of 113 breast cancer patients. Unsupervised clustering based on PET and MRI radiomic features created three subgroups. These derived subgroups were statistically significantly associated with tumor grade (p = 2.0 x 10(-6)), tumor overall stage (p = 0.037), breast cancer subtypes (p = 0.0085), and disease recurrence status (p = 0.0053). The PET-derived first-order statistics and gray level co-occurrence matrix (GLCM) textural features were discriminative of breast cancer tumor grade, which was confirmed by the results of L2-regularization logistic regression (with repeated nested cross-validation) with an estimated area under the receiver operating characteristic curve (AUC) of 0.76 (95% confidence interval (CI) = [0.62, 0.83]). The results of ElasticNet logistic regression indicated that PET and MR radiomics distinguished recurrence-free survival, with a mean AUC of 0.75 (95% CI = [0.62, 0.88]) and 0.68 (95% CI = [0.58, 0.81]) for 1 and 2 years, respectively. The MRI-derived GLCM inverse difference moment normalized (IDMN) and the PET-derived GLCM cluster prominence were among the key features in the predictive models for recurrence-free survival. In conclusion, radiomic features from PET and MR images could be helpful in deciphering breast cancer phenotypes and may have potential as imaging biomarkers for prediction of breast cancer recurrence-free survival.
引用
收藏
页数:13
相关论文
共 44 条
[1]  
Kumar V., Et al., Radiomics: the process and the challenges, Magn. Reson. Imaging, 30, pp. 1234-1248, (2012)
[2]  
Lambin P., Et al., Radiomics: extracting more information from medical images using advanced feature analysis, Eur. J. Cancer, 48, pp. 441-446, (2012)
[3]  
Aerts H.J.W.L., Et al., Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat. Commun., 5, (2014)
[4]  
Nicolasjilwan M., Et al., Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients, J. Neuroradiol., 42, pp. 212-221, (2015)
[5]  
Segal E., Et al., Decoding global gene expression programs in liver cancer by noninvasive imaging, Nat. Biotechnol., 25, pp. 675-680, (2007)
[6]  
Cook G.J.R., Et al., Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy?, J. Nucl. Med., 54, pp. 19-26, (2013)
[7]  
Coroller T.P., Et al., CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma, Radiother. Oncol., 114, pp. 345-350, (2015)
[8]  
Parmar C., Et al., Radiomic feature clusters and prognostic signatures specific for lung and head and neck cancer, Sci. Rep., 5, pp. 1-10, (2015)
[9]  
Lambin P., Et al., Radiomics: the bridge between medical imaging and personalized medicine, Nat. Rev. Clin. Oncol., 14, pp. 749-762, (2017)
[10]  
Win T., Et al., Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non–small cell lung cancer, Clin. Cancer Res., pp. 3591-3600, (2013)